Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Receivables (2016 - 2025)

Historic Receivables for Pharma-Bio Serv (PBSV) over the last 17 years, with Q4 2025 value amounting to $5.3 million.

  • Pharma-Bio Serv's Receivables rose 11107.89% to $5.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $5.3 million, marking a year-over-year increase of 11107.89%. This contributed to the annual value of $5.3 million for FY2025, which is 0.0% changed from last year.
  • Latest data reveals that Pharma-Bio Serv reported Receivables of $5.3 million as of Q4 2025, which was up 11107.89% from $2.0 million recorded in Q3 2025.
  • Pharma-Bio Serv's 5-year Receivables high stood at $10.4 million for Q2 2021, and its period low was $572000.0 during Q4 2021.
  • For the 5-year period, Pharma-Bio Serv's Receivables averaged around $5.1 million, with its median value being $5.0 million (2022).
  • Its Receivables has fluctuated over the past 5 years, first crashed by 9411.98% in 2021, then soared by 77106.64% in 2022.
  • Pharma-Bio Serv's Receivables (Quarter) stood at $572000.0 in 2021, then soared by 771.07% to $5.0 million in 2022, then fell by 20.91% to $3.9 million in 2023, then crashed by 36.29% to $2.5 million in 2024, then skyrocketed by 111.08% to $5.3 million in 2025.
  • Its Receivables was $5.3 million in Q4 2025, compared to $2.0 million in Q3 2025 and $5.3 million in Q2 2025.